Viewing Study NCT01416116

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT01416116
Status: COMPLETED
Last Update Posted: 2018-04-23
First Post: 2011-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None or Peripheral Nerve Injury (PNI) View
None Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tramadol View
None QUTENZA View
None Pre-treatment View
None Tolerability View